Skip to content

Concentrated growth factors for closure of oroantral communications after tooth extraction: A randomized controlled clinical trial

Concentrated growth factors for closure of oroantral communications after tooth extraction: A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084655
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oroantral communications

Interventions

experimental group:Using CGF to fill the extraction wound in the OAC area, covering it with a layer of CGF film, shaping the film to overlap with the edge of the extraction wound by 2-3mm, and fixing
control group:Fix the blood clot in the extraction socket using an 8-shaped suture.

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? Maxillary premolars or molars meet the indications for tooth extraction ? Before tooth extraction, CBCT showed that the root of the tooth entered the maxillary sinus. After tooth extraction, the Valsalva test was positive, and CBCT showed that the maximum diameter of continuous cortical loss in the maxillary sinus floor was 3-5mm ? Adults (18 years = 70 years) are willing and able to provide informed consent

Exclusion criteria

Exclusion criteria: ? Oral maxillary sinus traffic caused by tooth extraction, including but not limited to maxillary sinus elevation surgery, malignant tumors, odontogenic cysts, and tumor like diseases, osteomyelitis, radiation-induced osteonecrosis, and drug-related jawbone necrosis ? Suffering from stage III or IV periodontitis (most severe site of adjacent clinical attachment loss = 5mm or radiographic bone loss extending to the middle one-third or more of the tooth root) ? Acute inflammation of the maxillary sinus or uncontrolled chronic inflammation of the maxillary sinus ? Acute infectious diseases in the mouth ? Severe heart disease (those who have experienced myocardial infarction within six months, recent frequent occurrences of angina, etc.) ? Severe hematological diseases (hemophilia, leukemia, malignant lymphoma, etc.) ? Active infectious diseases that may affect normal healing ? Liver or renal insufficiency/failure ? Currently undergoing cancer treatment or within 18 months after completing radiotherapy or chemotherapy ? Uncontrolled diabetes: HbA1c>7.0% or fasting blood glucose>8.88mmol/L (160mg/dl) ? Pregnancy or in the preparatory stage ? Excessive tobacco use (smoking>10 cigarettes/day) ? Ingestion of drugs known to have a significant impact on bone or soft tissue metabolism, such as anti bone resorptive drugs (bisphosphonates, etc.)

Design outcomes

Primary

MeasureTime frame
The vertical height of new bone;

Secondary

MeasureTime frame
The volume of new bone;The density of new bone;soft tissue primary closure rate;Improved Masse Healing Index;VAS pain grade;

Countries

China

Contacts

Public ContactLu Jiayu

Shanghai Sixth People's Hospital

angelinelu2005@hotmail.com+86 139 1642 7000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026